News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
454 Results
Type
Article (33)
Press Release (421)
Section
Business (91)
Deals (13)
Drug Development (5)
FDA (13)
Job Trends (9)
News (243)
Policy (146)
Tag
Alliances (10)
Approvals (15)
Best Places to Work (1)
Biosimilars (1)
Cancer (1)
Clinical research (5)
Collaboration (1)
Data (1)
Earnings (48)
Events (3)
FDA (15)
Government (18)
Healthcare (6)
IPO (1)
Job creations (8)
Legal (89)
Medical device (1)
Medtech (1)
Mergers & acquisitions (13)
NextGen: Class of 2026 (4)
Non-profit (1)
Pain (3)
People (31)
Phase 3 (2)
Pipeline (5)
Postmarket research (3)
Real estate (4)
Regulatory (42)
Research institute (1)
Startups (1)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (10)
2026 (4)
2025 (10)
2024 (20)
2023 (19)
2022 (79)
2021 (39)
2020 (41)
2019 (24)
2018 (21)
2017 (11)
2016 (15)
2015 (6)
2014 (21)
2013 (14)
2012 (9)
2011 (11)
2010 (12)
Location
Asia (29)
Australia (2)
California (3)
Canada (13)
Europe (51)
Florida (3)
Indiana (1)
Northern California (3)
South America (1)
United States (8)
Washington D.C. (1)
454 Results for "apotex".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apotex announces leadership changes
March 30, 2026
·
2 min read
Press Releases
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada’s Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
March 25, 2026
·
1 min read
Press Releases
Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal
February 5, 2026
·
4 min read
Press Releases
Apotex Receives Health Canada Approval for LOQTORZI® -- The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer
October 24, 2025
·
2 min read
Press Releases
Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats
July 3, 2025
·
2 min read
Apotex to Participate in the Jefferies Global Healthcare Conference 2024
Apotex Inc. announced that Allan Oberman, President & CEO, will be presenting at the Jefferies Healthcare Conference on Wednesday, June 5th, 2024 at 9:00 am EST in New York, NY.
June 4, 2024
·
1 min read
Deals
Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader
Canada’s largest pharmaceutical company, Apotex Inc. and Searchlight Pharma Inc. (“Searchlight”), one of Canada’s fastest growing companies, announced today that they have reached an agreement whereby Apotex will acquire Searchlight.
April 2, 2024
·
4 min read
BioMidwest
Apotex Corp. Launches Generic Fertility Treatment Injectable Cetrorelix® in the United States
Apotex Corp. announced the launch of Cetrorelix Acetate for Injection 0.25mg, a generic version of Cetrotide® in the United States.
May 14, 2024
·
1 min read
Press Releases
Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal
February 25, 2025
·
4 min read
Deals
Apotex Completes Acquisition of Searchlight, a leading Canadian-based Specialty Innovative Branded Pharmaceutical Company
TORONTO, June 3, 2024 /PRNewswire/ - Apotex Inc. announced the successful completion of its acquisition of Searchlight Pharma Inc., a leading Canadian specialty innovative branded pharmaceutical company.
June 3, 2024
·
2 min read
1 of 46
Next
